Log In
Print
BCIQ
Print
Print this Print this
 

IMCgp100, ImmTAC-gp100

  Manage Alerts
Collapse Summary General Information
Company Immunocore Ltd.
DescriptionMonoclonal T cell receptor anti-CD3 scFv fusion protein that activates T cells against silver homolog (SILV; PMEL17; GP100)
Molecular Target Not applicable
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPhase II
Standard IndicationMelanoma
Indication DetailsTreat advanced malignant melanoma; Treat advanced unresectable melanoma; Treat melanoma
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today